Peter Cashin

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

Peter Cashin, Haile Mahteme, N. Spång et al. · European Journal of Cancer · 2016 · 182 citations

Cytoreductive Surgery, Surgical Oncology, Gastrointestinal Oncology +8

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)

Matilda Bushati, Koen P. Rovers, Antonio Sommariva et al. · European Journal of Surgical Oncology · 2018 · 144 citations

Cytoreductive Surgery, Worldwide Web-based Survey, Surgical Oncology +8

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

Shigeki Kusamura, Vahan Képénékian, Laurent Villeneuve et al. · European Journal of Surgical Oncology · 2020 · 120 citations

Surgical Oncology, Surgical Pathology, Pathology +3

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study

Peter Cashin, W. Graf, Peter Nygren et al. · European Journal of Surgical Oncology · 2012 · 101 citations · Full text

Cytoreductive Surgery, Surgical Oncology, Intraperitoneal Chemotherapy +9

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC

Wilhelm Graf, Peter Cashin, Lana Ghanipour et al. · Annals of Surgical Oncology · 2019 · 60 citations · Full text